What is THC Therapeutics Inc?
It develops dHydronator, a sanitizing herb/cannabis dryer.
THCT · Verdict
Limited reward · high risk
THCT has limited near-term tailwinds — cash flow and volatility weigh on the model output.
Based on 88% data coverage
THCT · Verdict
Weak vs peers
Weak vs peers
Current ratio 0.00
0% return on equity
Earnings -41.0% CAGR
Model-based scoring. For information only — not financial advice.
It develops dHydronator, a sanitizing herb/cannabis dryer. The company was formerly known as Millennium Blockchain, Inc. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 38.87K.
The scoring profile indicates weak reward characteristics across most factors, including valuation and momentum. Risk indicators are high — this profile reflects meaningful downside exposure.
For informational purposes only. Not financial advice.